The role of <i>Bifidobacterium</i> genus in modulating the neonate microbiota: implications for antibiotic resistance acquisition in early lifeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This observational study asked whether Bifidobacterium abundance in the newborn gut shapes the early antibiotic resistance gene load. Researchers profiled the microbiota by 16S rRNA amplicon sequencing at two ages. They quantified Bifidobacterium and resistance genes for tetracycline, beta-lactams, and erythromycin by targeted qPCR. Infants were split by k-means into high and low Bifidobacterium clusters. The team then tested which perinatal factors (delivery mode, feeding, antibiotic exposure) drove composition and resistance.
Who was studied?
The sample was 200 fecal samples from healthy term infants in the Spanish MAMI birth cohort, recruited in 2015-2017 with maternal-neonatal clinical records. Stool was collected at two time points: 7 days and 1 month after birth. A subset was used for resistance gene qPCR, with 71 samples at 7 days and 66 at 1 month. Most infants were vaginally born and breastfed.
What were the most important findings?
Infants split into two clusters by Bifidobacterium abundance. The high cluster averaged 54.4 percent Bifidobacterium at 7 days and 61.7 percent at 1 month, versus 11.3 and 17.1 percent in the low cluster. Lower Bifidobacterium tracked with higher resistance gene load. Low-cluster infants had more Bacteroides, Escherichia, and other genera that carry resistance genes. At 7 days, 42.1 percent of low-cluster infants were exposed to antibiotics at delivery, versus far fewer high-cluster infants (p = 0.0008). Vaginal birth and breastfeeding favored the high-Bifidobacterium cluster.
What are the greatest implications of this study?
The results suggest Bifidobacterium dominance is a useful marker of a lower antibiotic resistance burden in early life. When bifidobacteria are scarce, resistance-carrying genera appear to fill the niche. Delivery mode and antibiotic exposure at birth were key drivers of low Bifidobacterium. The design is observational and correlational, so causation cannot be inferred. The findings support strategies that promote early bifidobacterial colonization, such as vaginal birth and breastfeeding.